Disclosure 0001966716-26-000012-2

SEC FORM 4

$86,931.56

Stoke Therapeutics, Inc. (STOK)

Sale of 2,716 shares at $32.0072 per share.

Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code S

Traded Aug 18, 2026 · Disclosed Aug 18, 2026

Source: SEC Form 4 · 0001966716-26-000012 · filed 2026-08-18 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Stoke Therapeutics, Inc. (STOK)." Disclosed 2026-08-18. https://desqlong.com/cards/0001966716-26-000012-2 (retrieved 2026-09-26).